Abishek Balakrishnan
Investor
Norwest
Norwest growth equity investor focused on healthcare services, IT, devices, and digital health.
Professional summary
John McNeil is a Norwest investor focused on venture opportunities in healthcare, including digital health, healthcare IT, technology-enabled healthcare services, medical devices, diagnostics, and biopharma. Before joining Norwest, he spent three years at ClearView Healthcare Partners advising life sciences clients on R&D and commercial strategy and conducting due diligence on potential M&A targets. His Norwest active companies include Engrail Therapeutics, Ouro Medicines, and Zenas BioPharma.
Selected portfolio companies the partner has backed
Career, education, and skills
12 more profiles